Stemgent

About:

Stemgent is a provider of reagents, services and training for scientists who study cellular reprogramming (iPS cells).

Website: http://www.stemgent.com

Twitter/X: Stemgent

Top Investors: Frazier Healthcare Partners, Morgenthaler Ventures, HealthCare Ventures

Description:

Stemgent works alongside some of the world's leading stem cell scientists in developing innovative technology and application solutions that provide researchers the tools to investigate and understand cellular reprogramming. Our mission is to help simplify and support stem cell research by producing products and services being designed by leading stem cell researchers. Specialties Cellular Reprogramming, iPS Cells, Media, Human iPSC Training & Services, mRNA Reprogramming, Stem Cell Research, Custom iPS cell lines, Pluriton, WIT, StainAlive, NutriStem